During the past decade, Southern California Dermatology, Inc. conducted 30 clinical trials. In the 10-year time frame, 30 clinical trials started and 21 clinical trials were completed, i.e. on average, 70% percent of trials that started reached the finish line to date. In the past 5 years, 12 clinical trials started and 20 clinical trials were completed. i.e. 166.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Southern California Dermatology, Inc." #1 sponsor was "Eli Lilly and Company" with 11 trials, followed by "Pfizer" with 6 trials sponsored, "Boehringer Ingelheim" with 3 trials sponsored, "Cassiopea SpA" with 2 trials sponsored and "Janssen Research & Development, LLC" with 2 trials sponsored. Other sponsors include 1 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Southern California Dermatology, Inc." #1 collaborator was "Dermira, Inc." with 3 trials as a collaborator, "Incyte Corporation" with 2 trials as a collaborator and "Allergan" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Southern California Dermatology, Inc." are "Atopic Dermatitis" (7 trials), "Psoriasis" (6 trials), "Acne Vulgaris" (3 trials), "Alopecia Areata" (3 trials) and "Dermatitis, Atopic" (2 trials). Many other conditions were trialed in "Southern California Dermatology, Inc." in a lesser frequency.

Most popular intervention types in "Southern California Dermatology, Inc." are "Drug" (27 trials), "Biological" (4 trials) and "Other" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (15 trials), "Lebrikizumab" (4 trials), "Guselkumab" (3 trials), "Baricitinib" (2 trials) and "CB-03-01 cream, 1%" (2 trials). Other intervention names were less common.

The vast majority of trials in "Southern California Dermatology, Inc." are 30 trials for "All" genders.

Currently, there are NaN active trials in "Southern California Dermatology, Inc.". undefined are not yet recruiting, 2 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 21 completed trials in Southern California Dermatology, Inc., undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Southern California Dermatology, Inc., 0 "Phase 1" clinical trials were conducted, 8 "Phase 2" clinical trials and 21 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 0 trials that are defined as “Not Applicable".